Diagnostic value of vacuum-assisted breast biopsy for breast carcinoma: a meta-analysis and systematic review

  title={Diagnostic value of vacuum-assisted breast biopsy for breast carcinoma: a meta-analysis and systematic review},
  author={Ying-hua Yu and Chi Liang and Xianhong Yuan},
  journal={Breast Cancer Research and Treatment},
As mammography screening has its limitation in diagnosis in breast carcinoma, minimally invasive procedures offer a better option. We conducted a systematic review to establish the overall value of Vacuum-assisted breast biopsy (VAB) for the diagnosis of breast cancer. After a review and quality assessment of 21 studies, sensitivity, specificity and other measures of accuracy of VAB for evaluating breast lesions were pooled using random-effects models. Summary receiver operating characteristic… 

High risk (B3) breast lesions: What is the incidence of malignancy for individual lesion subtypes? A systematic review and meta-analysis.

  • N. ForesterS. LowesE. MitchellM. Twiddy
  • Medicine
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
  • 2019

Predictive factors for breast cancer in patients diagnosed with ductal intraepithelial neoplasia, grade 1B.

From this large series, there was unable to define any accurate safety model for breast cancer, and surgery should be thus recommended.

A systematic review on the use of the breast lesion excision system in breast disease

The BLES, an automated, image-guided, single-pass biopsy system for breast lesions using radiofrequency is an efficient and safe breast biopsy method with acceptable complication rates, which may be used as an alternative to vacuum-assisted biopsies.

Positive predictive value for malignancy on surgical excision of breast lesions of uncertain malignant potential (B3) diagnosed by stereotactic vacuum-assisted needle core biopsy (VANCB): A large multi-institutional study in Italy The Breast

This study, to date the largest series of B3 with positive histological assessment on SE, suggests that B3 lesions should be referred for SE even if VANCB is more accurate than NCB in the diagnostic process of non-palpable, sonographically invisible breast lesions.

Upgrade rates and outcomes of screen-detected atypical intraductal epithelial proliferation (AIDEP) diagnosed on core needle biopsy.

The data showing an upgrade rate of 28% to carcinoma reflects recently published data and is believed to support the continued practice of excising AIDEP to exclude co-existing carcinoma.

Role of one-pass breast lesion excision system in complete excision of high-risk breast lesions with atypia expressed as clusters of microcalcifications

One-pass BLES intact biopsy technique is a safe method of complete removal of high-risk atypical lesions with high accuracy rates for certain histologies and could be potentially used as an alternative excision method to diagnostic surgery in selected cases.



A comparison of the accuracy of two minimally invasive breast biopsy methods: a systematic literature review and meta-analysis

The best available evidence suggests that, in screening populations referred for minimally invasive breast biopsy biopsy requiring ST guidance, DVAB may provide lower miss and underestimation rates for clinically relevant diagnoses than does CNB.

Diagnostic accuracy of large-core needle biopsy for nonpalpable breast disease: a meta-analysis

The results of this meta-analysis indicate that the image guided large-core needle biopsy is a promising alternative for the needle localized breast biopsy, however, additional research is needed to explore the limiting factors of the technique.

Underestimation of atypical ductal hyperplasia at MRI-guided 9-gauge vacuum-assisted breast biopsy.

ADH at MRI-guided vacuum-assisted breast biopsy is an indication for surgical excision because of the high frequency of underestimation of these lesions, and an ADH underestimation rate of 38% is indicated.

Reliability of histologic diagnosis of breast cancer with stereotactic vacuum-assisted biopsy.

Using 11-gauge stereotactic vacuum-assisted breast biopsy the diagnosis of invasive carcinoma is reliable, however, a percutaneous finding of DCIS does not exclude the presence of invasion in 9% of cases as confirmed by subsequent surgery.

Ultrasound-guided core needle biopsy of the breast: does frozen section give an accurate diagnosis?

Immediate investigation of CNB in frozen sections is an accurate diagnostic method and an important step in reducing psychological strain on patients with breast tumors and may be offered by specialised Breast Assessment Units.

Is zero underestimation feasible? Extended Vacuum-assisted breast biopsy in solid lesions – a blind study

The extended protocol seems to totally excise precursor lesions, with minimal underestimation, and might possibly point to a modified management of ADH lesions.

Accuracy and complication rates of US-guided vacuum-assisted core breast biopsy: initial results.

US-guided vacuum-assisted core breast biopsy is accurate, but there may be a slightly higher risk of bleeding, which may be related to the lack of breast compression during the procedure, when compared with biopsy performed with stereotactic guidance.

Accuracy of 11-Gauge Vacuum-Assisted Core Biopsy of Mammographic Breast Lesions

In patients with DCIS found by stereotactic biopsy, a target zone of calcifications >1.5 cm is associated with a higher underestimation rate of infiltrating disease, while in patients with ADH and ADH understages 13.2% and 13.5% of DCIS andADH lesions, respectively are understaged.